Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice
Clinical trial NCT06905301 · RECRUITING
Trial details
- NCT number
- NCT06905301
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-23
- Primary completion
- 2029-12-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.